| IPO Company Profile © ipodata.com |
| Message Board | Quote | Chart | News | SEC Filings | Peer IPO Companies |
| Medcath Corporation |
| 10720 Sikes Place, Suite 300, Charlotte, NC 28277 * (704) 708-6600 |
| Business Description | The company focuses on the diagnosis and treatment of cardiovascular disease. They designs, develops, owns and operates heart hospitals in partnership with highly regarded cardiologists and cardiovascular surgeons. |
| Offering Information Company has | |||
| Trading As | MDTH (NASNTL) | Industry | Service (SIC 8062) |
| Type of Stock Offered | Common Shares | Filing Date | 5/4/2001 |
| Domestic Shares Offered | 6,000,000 | Offer Date | 7/23/2001 |
| Foreign Shares Offered | 0 | Filing Range | $24.00 - $26.00 |
| Company Shares | 6,000,000 | Offer Price | $25.00 |
| Selling Shrhldrs Shares | 0 | Gross Spread | $1.750 |
| Gross Proceeds | $150,000,000 | Selling | $1.050 |
| Expenses | - - | Reallowance | $0.100 |
| Post-IPO Shares | 17,980,000 | Employees | 3273 |
| Primary Underwriting Group | ||
| Underwriter Name | Participation | Underwriter Phone |
| Deutsch Banc Alex. Brown | Lead Manager | (410) 727-1700 |
| Banc of America Securities LLC | Co-manager | (415) 627-2100 |
| First Union Securities, Inc. | Co-manager | |
| J.P. Morgan Securities Inc. | Co-manager | (212) 648-0517 |
| Income Statement and Cash Flow Summary | |||||||
| Prior Audited Income |
Latest Unaudited Income | ||||||
| Full Year Audited Figures | 6 Months Ending | ||||||
| Figures in U.S. millions except per share data | 6/30/1998 | 6/30/1999 | 6/30/2000 | 12/31/1999 | 12/31/2000 | ||
| Revenues | - | - | 5.350 | 3.159 | 16.123 | 7.537 | 12.266 |
| Income from Oper. | - | - | -1.675 | -1.643 | -2.822 | -0.870 | -1.059 |
| Net Income | - | - | -1.691 | -1.573 | -2.727 | -0.851 | -1.735 |
| E.P.S | - | - | -0.890 | -0.570 | -0.730 | -0.250 | -0.410 |
| Revenue Growth (%) | - | - | -40.95 | 410.383 | 62.74 | ||
| Net Income Growth (%) | - | - | - | - | - | ||
| Oper. Profit Margin (%) | - | - | - | - | - | - | - |
| Net Profit Margin (%) | - | - | - | - | - | - | - |
| Cash Flow - Oper. | -2.28 | -1.28 | -1.78 | ||||
| Cash Flow - Inv. | -3.02 | -0.80 | -3.58 | ||||
| Cash Flow - Fin. | 6.13 | 1.65 | 5.00 | ||||
| Balance Sheet Summary and Financial Ratios | |||||
| Balance sheet as of: 12/31/2000 | Financial Ratios | ||||
| Total Assets | 11.48 | Current Assets | 6.06 | Current Ratio | 1.71 |
| Total Liab. | 5.82 | Current Liab. | 3.55 | Debt Ratio | 50.65% |
| Total Equity | 5.67 | Working Cap. | 2.52 | Debt to Equity Ratio | 1.03 |
| Cash | 0.81 | Return on Assets | - | ||
| Use Of Proceeds |
The proceeds from the proposed offering will be used for general corporate purposes. |
| Legal Counsel Registrar Auditor | |
| Issuer's Law Firm | Moore & Van Allen |
| Bank's Law Firm | Willkie Farr & Gallagher |
| Auditor | Deloitte & Touche |
| Send us feedback if you would like to request that we hyperlink a firm on this page | |